1. 2022-RA-1474-ESGO Traditional systemic treatment options in advance low grade serous ovarian cancer after successful cytoreduction. A systematic review and meta-analysis. (20th October 2022) Authors: Macías, Rosa Montero; Rigolet, Pascal; Mikhael, Elie; Krell, Jonathan; Villefranque, Vincent; Lecuru, Fabrice; Fotopoulou, Christina Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1505-ESGO Ovarian cancer retrospective European (O'CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression. (20th October 2022) Authors: Krell, Jonathan; Madhuri, Thumulurua K; Shaw, Danielle; McGrane, John; Anand, Anjana; Hartkopf, Andreas; Herrero, Ana; Yeoh, Cheng; Masvidal, Maria; Fumet, Jean-David; Rogmans, Gunther; Raspagliesi, Francesco; Gavoille, Celine; York, Whitney; Schilder, Jeanne M; Mascialino, Barbara; McDermott, El... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1608-ESGO Clinical implications of genomic intratumoural heterogeneity in high grade serous ovarian cancer. (20th October 2022) Authors: Cunnea, Paula; Christie, Elizabeth L; Curry, Ed; Kwok, Chun-Hei; Pandey, Ahwan; Nixon, Katherine; Ploski, Jennifer; Krell, Jonathan; McNeish, Iain; Bowtell, David D; Fotopoulou, Christina Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. (10th December 2020) Authors: Lythgoe, Mark; Stebbing, Justin; Pickford, Emily; Glasmacher, Axel; Adriani, Marsilio; Fyvie, Gayle; Frampton, Adam; Stevenson, Alex; Krell, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours. (9th November 2020) Authors: Lythgoe, Mark; Stebbing, Justin; Pickford, Emily; Glasmacher, Axel; Adriani, Marsilio; Fyvie, Gayle; Frampton, Adam; Stevenson, Alex; Krell, Jonathan Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A microRNA meta-signature for pancreatic ductal adenocarcinoma. (April 2014) Authors: Frampton, Adam E; Giovannetti, Elisa; Jamieson, Nigel B; Krell, Jonathan; Gall, Tamara MH; Stebbing, Justin; Jiao, Long R; Castellano, Leandro Journal: Expert review of molecular diagnostics Issue: Volume 14:Number 3(2014) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A review of the role of transfer RNAs within extracellular vesicles as a potential marker in cancer diagnostics. Issue 1 (January 2023) Authors: Clayton Yang, Qi Zhi; Liu, Daniel S.K.; Asim, Mohammad; Krell, Jonathan; Frampton, Adam E. Journal: European journal of surgical oncology Issue: Volume 49:Issue 1(2023) Page Start: e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas. (March 2015) Authors: Frampton, Adam E; Stebbing, Justin; Gall, Tamara MH; Silver, Benjamin; Jiao, Long R; Krell, Jonathan Journal: Expert review of molecular diagnostics Issue: Volume 15:Number 3(2015) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Altered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers. (January 2013) Authors: Pellegrino, Loredana; Jacob, Jimmy; Roca-Alonso, Laura; Krell, Jonathan; Castellano, Leandro; Frampton, Adam E Journal: Expert review of anticancer therapy Issue: Volume 13:(2013)Supplement 1 Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment. (2nd July 2016) Authors: Le Large, Tessa Y.S.; Mato Prado, Mireia; Krell, Jonathan; Bijlsma, Maarten F.; Meijer, Laura L.; Kazemier, Geert; Frampton, Adam E.; Giovannetti, Elisa Journal: Expert review of molecular diagnostics Issue: Volume 16:Number 7(2016) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗